UBS Group AG - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 80 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q1 2023$8,257
-31.2%
18,681
+81.5%
0.00%
Q4 2021$12,000
+33.3%
10,294
+250.1%
0.00%
Q2 2021$9,000
-60.9%
2,940
-56.9%
0.00%
Q1 2021$23,000
-4.2%
6,814
+36.3%
0.00%
Q4 2020$24,000
+380.0%
4,998
+399.8%
0.00%
Q3 2020$5,000
-81.5%
1,000
-87.7%
0.00%
Q2 2020$27,000
-65.4%
8,103
-46.1%
0.00%
Q1 2020$78,000
-36.1%
15,043
-43.9%
0.00%
Q4 2019$122,000
-26.1%
26,814
-0.3%
0.00%
Q3 2019$165,000
+1.9%
26,893
+1.0%
0.00%
Q2 2019$162,000
+21.8%
26,621
+10.9%
0.00%
Q1 2019$133,000
+454.2%
24,000
+476.9%
0.00%
Q4 2018$24,000
-33.3%
4,160
+19.5%
0.00%
Q3 2018$36,000
+24.1%
3,480
+34.6%
0.00%
Q2 2018$29,000
+61.1%
2,586
+12.4%
0.00%
Q1 2018$18,000
-28.0%
2,300
-22.8%
0.00%
Q4 2017$25,000
-64.8%
2,978
-74.0%
0.00%
Q3 2017$71,000
+4.4%
11,460
+1.3%
0.00%
Q2 2017$68,000
+38.8%
11,317
+21.7%
0.00%
Q1 2017$49,000
-57.0%
9,300
-44.7%
0.00%
Q4 2016$114,000
-5.8%
16,827
+2.8%
0.00%
Q3 2016$121,000
+1.7%
16,369
+13.2%
0.00%
Q2 2016$119,000
+95.1%
14,461
+42.4%
0.00%
Q1 2016$61,000
+408.3%
10,157
+341.6%
0.00%
Q4 2015$12,000
-25.0%
2,300
-42.8%
0.00%
Q3 2015$16,0000.0%4,020
+26.1%
0.00%
Q2 2015$16,0003,187
+12648.0%
0.00%
Q1 2015$0
-100.0%
25
-99.4%
0.00%
Q4 2014$16,0004,0380.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Penbrook Management LLC 344,060$1,634,0001.26%
Union Square Park Capital Management, LLC 400,000$1,900,0000.76%
P.A.W. CAPITAL CORP 100,000$475,0000.42%
PRECEPT MANAGEMENT LLC 150,000$713,0000.29%
Newbridge Financial Services Group, Inc. 73,500$349,0000.29%
SANDERS MORRIS HARRIS LLC 183,584$990,0000.22%
FRIESS ASSOCIATES LLC 555,000$2,636,0000.19%
PERRITT CAPITAL MANAGEMENT INC 30,651$146,0000.09%
Ikarian Capital, LLC 219,109$1,041,0000.05%
SEGALL BRYANT & HAMILL, LLC 705,823$3,352,0000.04%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders